Lunai Bioworks names 10 defendants in alleged naked short-selling fraud lawsuit - LNAI News | RalliesLunai Bioworks names 10 defendants in alleged naked short-selling fraud lawsuit
L
LNAI• Claims and possible additional defendants
- Claims include securities fraud, market manipulation, civil conspiracy, racketeering, common law fraud, tortious interference; jury trial demanded.
- Plaintiff signals more defendants may be added as discovery and trading-data analysis continues.
Lunai Bioworks names 10 defendants in Delaware federal complaint
- Lunai Bioworks filed a first amended complaint in Delaware federal court naming 10 defendants over an alleged coordinated naked short-selling scheme.
- Suit seeks treble damages under federal RICO, citing alleged failures to deliver of 29.6 million shares, or more than 81% outstanding.
- Complaint alleges short sales violated Regulation SHO from November 2025 through May 2026, pointing to 554,032,865 shares traded on March 17, 2026.
SUGP
•
